Learn more about the member entities

Complementary expertise network

The Carnot Institute CALYM is based on the strategic articulation of 20 organisations, possessing complementary expertise in lymphoma research: 18 public research teams, the LYSA Cooperating Group and the academic research organisation LYSARC.

Network CALYM

  • All laboratories
  • Type of lymphoma
    • B-cell lymphoma
    • Burkitt lymphoma
    • Diffuse large B cell lymphoma (DLBCL)
    • Follicular lymphoma (LF)
    • Hodgkin lymphoma
    • Mantle cell lymphoma (MCL)
    • T-cell lymphoma
  • Type of research
    • Biomarkers
    • Epigenetics
    • Immunotherapy
    • Mitochondria
    • Oncogenesis of T lymphomas
    • Unicellular RNA-seq
Jerome Moreaux Experts Recherche Lymphome
IGH - Institute of Human Genetics
Maintenance of genome integrity during DNA replication / Epigenetic changes and genetic instability in normal and tumor B cells.
Pascal Bilbault Innovation Lymphome
The lymphoma Academic Research Organisation
Integrative immunology of B lymphomas
Immunology and oncogenesis of lymphoid tumours
Bertrand Nadel et Sandrine Roulland Innovation Lymphome
Genomic instability and human blood diseases
Karin Tarte Innovation Lymphome
UMR U1236
Microenvironment Cell differentiation, iMmunology And Cancer (MICMAC)
Genomics and biomarkers of lymphomas and solid tumours
Daniel Olive Innovation Lymphome
INSERM UMR 1068 Marseille Cancer Research Centre
Immunity and cancer
Olivier Hermine Recherche Lymphome
INSERM U1163 Institut des maladies génétiques IMAGINE
Cell and molecule mechanisms of haematological disorders and therapeutic implications
UMR 1170 - Institut Gustave Roussy
Early stages of the transformation of haematopoietic cells
UMR @CNRS 7276 @Inserm 1262 CRIBL
Monitoring the B-cell immune response and lymphoproliferation
Laurent Genestier Innovation Lymphome
Lymphoma Immuno-Biology (LIB)
UMR INSERM 1052 CNRS 5286 Centre Léon Bérard - Lyon Cancer Research Centre
Anticancer antibodies
Catherine Pellat-Deceunynck
Regulation of Bcl2 and p53 networks in Multiple Myeloma and Mantle Cell Lymphoma
Innovations thérapeutiques des lymphomes B, INSERM UMR1037, Equipe n°9 Centre de recherche en cancérologie de Toulouse
NoLymIT : New Immunotherapies Against Lymphoma
Identifying, at the single cell level, the mechanisms linked to lymphocyte exhaustion in lymphomas…
Jean-Ehrland RICCI membre de l'Institut Carnot CALYM
Metabolism, cancer and immune responses
Metabolism, cancer and immune responses
LYSA - The Lymphoma Study Association